Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

M. Ilander, U. Olsson-Stromberg, H. Schlums, J. Guilhot, Oscar Bruck, H. Lahteenmaki, T. Kasanen, P. Koskenvesa, S. Soderlund, M. Hoglund, B. Markevarn, A. Sjalander, K. Lotfi, A. Dreimane, A. Lubking, E. Holm, M. Bjoreman, S. Lehmann, L. Stenke, L. Ohm & 11 others T. Gedde-Dahl, W. Majeed, H. Ehrencrona, S. Koskela, S. Saussele, F-X Mahon, K. Porkka, H. Hjorth-Hansen, Y. T. Bryceson, J. Richter, S. Mustjoki

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalLeukemia
Volume31
Issue number5
Pages (from-to)1108-1116
Number of pages9
ISSN0887-6924
DOIs
Publication statusPublished - May 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • CHRONIC MYELOGENOUS LEUKEMIA
  • NATURAL-KILLER-CELLS
  • COMPLETE MOLECULAR REMISSION
  • CYTOMEGALOVIRUS-INFECTION
  • CML PATIENTS
  • IFN-GAMMA
  • IN-VIVO
  • DASATINIB
  • ACTIVATION
  • REJECTION
  • 3122 Cancers

Cite this

Ilander, M. ; Olsson-Stromberg, U. ; Schlums, H. ; Guilhot, J. ; Bruck, Oscar ; Lahteenmaki, H. ; Kasanen, T. ; Koskenvesa, P. ; Soderlund, S. ; Hoglund, M. ; Markevarn, B. ; Sjalander, A. ; Lotfi, K. ; Dreimane, A. ; Lubking, A. ; Holm, E. ; Bjoreman, M. ; Lehmann, S. ; Stenke, L. ; Ohm, L. ; Gedde-Dahl, T. ; Majeed, W. ; Ehrencrona, H. ; Koskela, S. ; Saussele, S. ; Mahon, F-X ; Porkka, K. ; Hjorth-Hansen, H. ; Bryceson, Y. T. ; Richter, J. ; Mustjoki, S. / Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia. In: Leukemia. 2017 ; Vol. 31, No. 5. pp. 1108-1116.
@article{d59f7acae76842b8b27d16adbd84cace,
title = "Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia",
keywords = "CHRONIC MYELOGENOUS LEUKEMIA, NATURAL-KILLER-CELLS, COMPLETE MOLECULAR REMISSION, CYTOMEGALOVIRUS-INFECTION, CML PATIENTS, IFN-GAMMA, IN-VIVO, DASATINIB, ACTIVATION, REJECTION, 3122 Cancers",
author = "M. Ilander and U. Olsson-Stromberg and H. Schlums and J. Guilhot and Oscar Bruck and H. Lahteenmaki and T. Kasanen and P. Koskenvesa and S. Soderlund and M. Hoglund and B. Markevarn and A. Sjalander and K. Lotfi and A. Dreimane and A. Lubking and E. Holm and M. Bjoreman and S. Lehmann and L. Stenke and L. Ohm and T. Gedde-Dahl and W. Majeed and H. Ehrencrona and S. Koskela and S. Saussele and F-X Mahon and K. Porkka and H. Hjorth-Hansen and Bryceson, {Y. T.} and J. Richter and S. Mustjoki",
year = "2017",
month = "5",
doi = "10.1038/leu.2016.360",
language = "English",
volume = "31",
pages = "1108--1116",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "5",

}

Ilander, M, Olsson-Stromberg, U, Schlums, H, Guilhot, J, Bruck, O, Lahteenmaki, H, Kasanen, T, Koskenvesa, P, Soderlund, S, Hoglund, M, Markevarn, B, Sjalander, A, Lotfi, K, Dreimane, A, Lubking, A, Holm, E, Bjoreman, M, Lehmann, S, Stenke, L, Ohm, L, Gedde-Dahl, T, Majeed, W, Ehrencrona, H, Koskela, S, Saussele, S, Mahon, F-X, Porkka, K, Hjorth-Hansen, H, Bryceson, YT, Richter, J & Mustjoki, S 2017, 'Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia', Leukemia, vol. 31, no. 5, pp. 1108-1116. https://doi.org/10.1038/leu.2016.360

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia. / Ilander, M.; Olsson-Stromberg, U.; Schlums, H.; Guilhot, J.; Bruck, Oscar; Lahteenmaki, H.; Kasanen, T.; Koskenvesa, P.; Soderlund, S.; Hoglund, M.; Markevarn, B.; Sjalander, A.; Lotfi, K.; Dreimane, A.; Lubking, A.; Holm, E.; Bjoreman, M.; Lehmann, S.; Stenke, L.; Ohm, L.; Gedde-Dahl, T.; Majeed, W.; Ehrencrona, H.; Koskela, S.; Saussele, S.; Mahon, F-X; Porkka, K.; Hjorth-Hansen, H.; Bryceson, Y. T.; Richter, J.; Mustjoki, S.

In: Leukemia, Vol. 31, No. 5, 05.2017, p. 1108-1116.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

AU - Ilander, M.

AU - Olsson-Stromberg, U.

AU - Schlums, H.

AU - Guilhot, J.

AU - Bruck, Oscar

AU - Lahteenmaki, H.

AU - Kasanen, T.

AU - Koskenvesa, P.

AU - Soderlund, S.

AU - Hoglund, M.

AU - Markevarn, B.

AU - Sjalander, A.

AU - Lotfi, K.

AU - Dreimane, A.

AU - Lubking, A.

AU - Holm, E.

AU - Bjoreman, M.

AU - Lehmann, S.

AU - Stenke, L.

AU - Ohm, L.

AU - Gedde-Dahl, T.

AU - Majeed, W.

AU - Ehrencrona, H.

AU - Koskela, S.

AU - Saussele, S.

AU - Mahon, F-X

AU - Porkka, K.

AU - Hjorth-Hansen, H.

AU - Bryceson, Y. T.

AU - Richter, J.

AU - Mustjoki, S.

PY - 2017/5

Y1 - 2017/5

KW - CHRONIC MYELOGENOUS LEUKEMIA

KW - NATURAL-KILLER-CELLS

KW - COMPLETE MOLECULAR REMISSION

KW - CYTOMEGALOVIRUS-INFECTION

KW - CML PATIENTS

KW - IFN-GAMMA

KW - IN-VIVO

KW - DASATINIB

KW - ACTIVATION

KW - REJECTION

KW - 3122 Cancers

U2 - 10.1038/leu.2016.360

DO - 10.1038/leu.2016.360

M3 - Article

VL - 31

SP - 1108

EP - 1116

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -